What does MaxCyte, Inc. do?

Jun 22 2025 06:16 PM IST
share
Share Via
MaxCyte, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, specializing in cell-based medicines. As of March 2025, it reported net sales of $10 million and a net loss of $10 million, with a market cap of $228.58 million.
Overview:
MaxCyte, Inc. focuses on cell-based medicines within the Pharmaceuticals & Biotechnology industry and operates in the micro-cap market.

Financial Snapshot:
Most recent Net Sales: 10 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -10 Million (Quarterly Results - Mar 2025)
Market-cap: USD 228.58 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.69
Return on Equity: -20.50%
Price to Book: 1.15

Contact Details:
Address: 22 Firstfield Rd Ste 110, GAITHERSBURG MD: 20878-1795
Tel: 1 301 9441700
Fax: 1 301 9441703
Website: https://www.maxcyte.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is MaxCyte, Inc. technically bullish or bearish?
Sep 20 2025 07:20 PM IST
share
Share Via
Is MaxCyte, Inc. overvalued or undervalued?
Sep 20 2025 05:55 PM IST
share
Share Via
Is MaxCyte, Inc. overvalued or undervalued?
Jun 25 2025 08:30 AM IST
share
Share Via
Is MaxCyte, Inc. technically bullish or bearish?
Jun 25 2025 08:27 AM IST
share
Share Via
Who are in the management team of MaxCyte, Inc.?
Jun 22 2025 10:15 PM IST
share
Share Via
How big is MaxCyte, Inc.?
Jun 22 2025 05:42 PM IST
share
Share Via